Expression of the Ror1 and Ror2 receptor tyrosine kinase genes during mouse development

被引:101
|
作者
Al-Shawi, R [1 ]
Ashton, SV [1 ]
Underwood, C [1 ]
Simons, JP [1 ]
机构
[1] UCL, Royal Free & Univ Coll Med Sch, Dept Anat & Dev Biol, London NW3 2PF, England
关键词
Ror1; Ror2; receptor tyrosine kinases; Robinow syndrome; brachydactyly;
D O I
10.1007/s004270100140
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ror1 and Ror2 are orphan receptor tyrosine kinases that are most closely related to MuSK and the Trk family of neurotrophin receptors. We report the re suits of an extensive in situ hybridisation survey of the expression of these genes during mouse development. Expression of Ror1 and Ror2 differs markedly at early stages (E8.5-E9.5). At these times, Ror2 is expressed much more widely than Ror1, expression of which is largely restricted to head mesenchyme. At later stages of development (E12.5-E14.5), Ror1 expression expands and Ror2 expression becomes more restricted than at earlier times? although expression of Ror1 continues to be more restricted than that of Ror2. These changes result in overlapping expression domains but with major differences remaining. In many cases Ror1 is expressed in a sub-set of Ror-2-expressing tissues; in others, there is complementary expression of Ror1 and Ror2. Ror1 and Ror2 are both expressed in derivatives of all three germ layers and in most organ systems, including the nervous, circulatory, respiratory, digestive, urogenital and skeletal systems. Conspicuous themes are the expression in major sense organs, and in neural crest and its derivatives.
引用
收藏
页码:161 / 171
页数:11
相关论文
共 50 条
  • [41] The ROR2 tyrosine kinase receptor regulates dendritic spine morphogenesis in hippocampal neurons
    Alfaro, Ivan E.
    Varela-Nallar, Lorena
    Varas-Godoy, Manuel
    Inestrosa, Nibaldo C.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2015, 67 : 22 - 30
  • [42] Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
    Yu, Jian
    Chen, Liguang
    Cui, Bing
    Widhopf, George F., II
    Shen, Zhouxin
    Wu, Rongrong
    Zhang, Ling
    Zhang, Suping
    Briggs, Steven P.
    Kipps, Thomas J.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (02): : 585 - 598
  • [43] Inhibition of the receptor tyrosine kinase ROR1 by anti-ROR1 monoclonal antibodies and siRNA induced apoptosis of melanoma cells
    Farsangi, Mohammad Hojat
    Ghaemimanesh, Fatemeh
    Daneshmanes, Amir Hossein
    Bayat, Ali-Ahmad
    Mahmoudian, Jafar
    Jeddi-Tehrani, Mahmood
    Mellstedt, Hakan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis
    Henry, Claire
    Hacker, Neville
    Ford, Caroline
    ONCOTARGET, 2017, 8 (68) : 112727 - 112738
  • [45] Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
    Henry, Claire
    Llamosas, Estelle
    Knipprath-Meszaros, Alexandra
    Schoetzau, Andreas
    Obermann, Ellen
    Fuenfschilling, Maya
    Caduff, Rosemarie
    Fink, Daniel
    Hacker, Neville
    Ward, Robyn
    Heinzelmann-Schwarz, Viola
    Ford, Caroline
    ONCOTARGET, 2015, 6 (37) : 40310 - 40326
  • [46] Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
    Juho Heliste
    Anne Jokilammi
    Ilkka Paatero
    Deepankar Chakroborty
    Christoffer Stark
    Timo Savunen
    Maria Laaksonen
    Klaus Elenius
    BMC Cardiovascular Disorders, 18
  • [47] Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
    Zhao, Yuming
    Zhang, Dengyang
    Guo, Yao
    Lu, Bo
    Zhao, Zhizhuang Joe
    Xu, Xiaojun
    Chen, Yun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [48] Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
    Heliste, Juho
    Jokilammi, Anne
    Paatero, Ilkka
    Chakroborty, Deepankar
    Stark, Christoffer
    Savunen, Timo
    Laaksonen, Maria
    Elenius, Klaus
    BMC CARDIOVASCULAR DISORDERS, 2018, 18
  • [49] The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
    Hojjat-Farsangi, Mohammad
    Khan, Abdul Salam
    Daneshmanesh, Amir Hossein
    Moshfegh, Ali
    Sandin, Asa
    Mansouri, Ladan
    Palma, Marzia
    Lundin, Jeanette
    Osterborg, Anders
    Mellstedt, Hakan
    PLOS ONE, 2013, 8 (10):
  • [50] Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
    Mikels, Amanda
    Minami, Yasuhiro
    Nusse, Roel
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (44) : 30167 - 30176